Center for Biomaterials and Biopathways, Department of Chemistry, Zhejiang University, Hangzhou 310027, China.
Cancer Institute (Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education), The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310009, China.
Sci Adv. 2020 Mar 20;6(12):eaaw9679. doi: 10.1126/sciadv.aaw9679. eCollection 2020 Mar.
Rhesus D (RhD) is one of the most important immunogenic antigens on red blood cells (RBCs). However, the supply of RhD-negative blood frequently faces critical shortages in clinical practice, and the positive-to-negative transition of the RhD antigen remains a great challenge. Here, we developed an alternative approach for sheltering the epitopes on RhD-positive RBCs using a surface-anchored framework, which is flexible but can achieve an optimal shield effect with minimal physicochemical influence on the cell. The chemical framework completely obstructed the RhD antigens on the cell surface, and the assessments of both blood transfusion in a mouse model and immunostimulation with human RhD-positive RBCs in a rabbit model confirmed the RhD-epitope stealth characteristics of the engineered RBCs. This work provides an efficient methodology for improving the cell surface for universal blood transfusion and generally indicates the potential of rationally designed cell surface engineering for transfusion and transplantation medicine.
恒河猴 D 血型(RhD)是红细胞(RBC)上最重要的免疫原性抗原之一。然而,在临床实践中,RhD 阴性血液的供应经常面临严重短缺,RhD 抗原的阳性到阴性的转变仍然是一个巨大的挑战。在这里,我们开发了一种使用表面锚定框架来保护 RhD 阳性 RBC 上表位的替代方法,该框架具有柔韧性,但可以在对细胞的最小物理化学影响下实现最佳的屏蔽效果。化学框架完全阻止了细胞表面上的 RhD 抗原,在小鼠模型中的输血评估和在兔模型中用人 RhD 阳性 RBC 进行的免疫刺激评估均证实了工程化 RBC 的 RhD-表位隐身特性。这项工作为改善通用输血的细胞表面提供了一种有效的方法,并且通常表明了合理设计的细胞表面工程在输血和移植医学方面的潜力。